Cargando…
Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism Is Not Responsible for Antihypertensive Therapy Induced New Onset of Type 2 Diabetes in Essential Hypertension
BACKGROUND: Antihypertensive drug therapies have been reported to be associated with new onset of type 2 diabetes mellitus in some hypertensive patients after prolonged use. Angiotensin converting enzyme (ACE) gene has been found to affect essential hypertension, response of antihypertensive therapi...
Autores principales: | Jhawat, Vikas, Gupta, Sumeet, Agarwal, Bimal K, Roy, Partha, Saini, Vipin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348549/ https://www.ncbi.nlm.nih.gov/pubmed/30718967 http://dx.doi.org/10.1177/1179551418825037 |
Ejemplares similares
-
Alpha Adducin (ADD1) Gene Polymorphism and New Onset of Diabetes Under the Influence of Selective Antihypertensive Therapy in Essential Hypertension
por: Gupta, Sumeet, et al.
Publicado: (2019) -
Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients
por: Tronvik, Erling, et al.
Publicado: (2008) -
The Insertion/Deletion Polymorphism of the Angiotensin Converting Enzyme (ACE) in Parkinson’s Disease
por: Papapetropoulos, Spiridon, et al.
Publicado: (2008) -
Insertion/Deletion Polymorphism of Angiotensin Converting Enzyme Gene in Kawasaki Disease
por: Shim, Yoon Hee, et al.
Publicado: (2006) -
Association of angiotensin converting enzyme gene insertion/deletion polymorphism with essential hypertension in south Indian population
por: Krishnan, Ramalingam, et al.
Publicado: (2016)